Last reviewed · How we verify
NCT05182827: TOUCH-S
Affective Touch, Hedonia and Suicidal Behavior
NA trial testing Tactile stimulation in Major Depressive Episode in 72 participants. Completed in 9 September 2024.
9 September 2024
Quick facts
| Lead sponsor | University Hospital, Montpellier |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 72 |
| Start date | 11 February 2022 |
| Primary completion | 9 September 2024 |
| Estimated completion | 9 September 2024 |
| Sites | 1 location across France |
Drugs / interventions tested
- Tactile stimulation
Conditions studied
- Major Depressive Episode — all drugs for Major Depressive Episode →
- Suicidal and Self-injurious Behavior — all drugs for Suicidal and Self-injurious Behavior →
Sponsor
University Hospital, Montpellier
Who can join
Adults 18 to 65, female only, with Major Depressive Episode or Suicidal and Self-injurious Behavior. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Several elements suggest that suicidal vulnerability may be associated with an alteration in the perception of affective touch. On the one hand, anhedonia, characterized by a decrease in the pleasure felt, is strongly associated with suicidal ideation, independently of depression. However, the ability to feel pleasure is essential in the perception of affective touch. On the other hand, suicidal behaviors are associated with interpersonal difficulties, of which communication is an integral part, and communication is partly through touch. The investigators therefore wish to explore the perception of affective touch in suicidal behavior by using an affective tactile stimulation in 72 subjects with and without a history of suicide attempts (SA).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05182827
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Tactile stimulation
Trials testing the same drug.
- NCT06231810 — Tracking a Tactile Signal Along the Nervous System · NA · recruiting
- NCT04844853 — Neural Correlates of Tactile Prediction · NA · unknown
Other recruiting trials for Major Depressive Episode
Currently open trials in the same condition.
- NCT07111390 — Feasibility of Home-Based Intermittent 60Hz Light Therapy for Major Depressive Disorder (MDD) · NA · recruiting
- NCT07269964 — At-Home tDCS as Maintenance Therapy · NA · recruiting
- NCT05973643 — Metabolomics During ElectroConvulsivoTherapy · NA · recruiting
- NCT04130958 — Circuit-Based Approach to Suicide: Biomarkers, Predictors, and Novel Therapeutics · NA · recruiting
- NCT06086366 — Presynaptic Imaging in Major Depressive Episodes After COVID-19 · recruiting
Other University Hospital, Montpellier trials
Trials by the same sponsor.
- NCT07524127 — Phenotyping of Type 2 Inflammation Profile by Rheology of Nasal Secretions and Tissue Quantification of Eosinophilic Pol · NA · not yet recruiting
- NCT07255495 — Effects of Neuromuscular Scoliosis Surgery on Nutritional Metabolism · NA · not yet recruiting
- NCT07534189 — Prospective Cohort Study Evaluating a Thermal Spa Programme in Symptomatic Knee Osteoarthritis · NA · not yet recruiting
- NCT07515638 — Immun4Cure Cohort of Autoimmune Diseases · not yet recruiting
- NCT07406516 — Identification of Kinematic Variables Specific of Patellar Tendinopathy in Athletes at Risk · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05182827 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Hospital, Montpellier
- Last refreshed: 10 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05182827.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing